Is FTC Lawsuit Altering The Investment Case For Hims Stock (HIMS)?
Hims & Hers Health is facing a class action in the Northern District of California after the FTC sued over…
23,780€
-1,90%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Hims & Hers Health (HIMS) Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit...…
Kaplan Fox Continues to Alert Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Class Action Deadline on November 2, 2026
Kaplan Fox Continues to Alert Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Class Action Deadline on…
Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $28.17, representing a +1.66% change from its…
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount…
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount…
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
/PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud…
HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline
Hims & Hers Systems Shareholders Between August 4, 2025 and July 29, 2026 - Contact Bernstein Liebhard For More Information…
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine…
HIMS trades flat as FTC complaint over health data sharing weighs
Hims & Hers Health trades at $27.71 today, down 0.4%. Regulatory risks and legal action weigh on shares amid volatile…
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
How to Switch From Hims & Hers to PlexusDx Without Missing a Dose
Hims & Hers requires $1,194 upfront for six months of compounded semaglutide. PlexusDx offers month-to-month semaglutide at $189 with no…
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead…
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential…
Hims & Hers shares technical analysis: Support test at $26.64 draws focus
Hims & Hers trades at $27.71 today, down 0.4%. Get the latest on HIMS price action, technicals, and trading range…
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
/PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has…
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit…
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who: Hims &…
Hims & Hers Health (HIMS) Faces FTC And Class Action Lawsuits, Is The Stock Still Undervalued?
Hims & Hers Health (HIMS) is in focus after the Federal Trade Commission filed a lawsuit over its health data…
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
/PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health,…
Why is Hims & Hers stock down today? FTC, Utah, Los Angeles lawsuit and seller pressure
Hims & Hers trades at $27.82, down 3% today amid legal challenges and regulatory scrutiny, with bearish momentum signals.…
FTC Hims and Hers Lawsuit: What the Telehealth Giant Didnt Want You to Know About Your Health Data
The San Francisco-based telehealth provider Hims & Hers Health, Inc., which built its reputation on convenience and discretion, was sued…
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before Lead Plaintiff Deadline on November 2, 2026
NEW YORK, NY - September 3, 2026 (NEWMEDIAWIRE) - Kaplan Fox (2) the Company charges consumers for prescriptions almost…
Is Hims & Hers Health Inc (HIMS) a Bargain After 3.0% Drop? GF Value Says Undervalued
On September 03, 2026, Hims & Hers Health Inc (HIMS) shares fell 3.0% to a current price of $27.82. The…
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
Hims & Hers Health shares fall over 3% as sellers reinforce pressure and technical weakness persists
Hims & Hers Health slides 3.17% today to $27.77 amid technical weakness and ongoing selling pressure in current trading.…